P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-06-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000847388.33116.c7 |
| _version_ | 1797285968814800896 |
|---|---|
| author | R. Owen H. McCarthy S. Rule S. D’Sa S. Thomas O. Tournilhac F. Forconi M. José Kersten P. Luigi Zinzani S. Iyengar J. Kothari M. Minnema E. Kastritis B. Cheson H. Walter D. Greewald R. Calvo C.-C. Wun R. Furman |
| author_facet | R. Owen H. McCarthy S. Rule S. D’Sa S. Thomas O. Tournilhac F. Forconi M. José Kersten P. Luigi Zinzani S. Iyengar J. Kothari M. Minnema E. Kastritis B. Cheson H. Walter D. Greewald R. Calvo C.-C. Wun R. Furman |
| author_sort | R. Owen |
| collection | DOAJ |
| first_indexed | 2024-03-07T18:10:45Z |
| format | Article |
| id | doaj.art-e6f75c206efb4b95b56fedbea92efbae |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T18:10:45Z |
| publishDate | 2022-06-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-e6f75c206efb4b95b56fedbea92efbae2024-03-02T07:47:21ZengWileyHemaSphere2572-92412022-06-0161020102110.1097/01.HS9.0000847388.33116.c7202206003-01020P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDYR. Owen0H. McCarthy1S. Rule2S. D’Sa3S. Thomas4O. Tournilhac5F. Forconi6M. José Kersten7P. Luigi Zinzani8S. Iyengar9J. Kothari10M. Minnema11E. Kastritis12B. Cheson13H. Walter14D. Greewald15R. Calvo16C.-C. Wun17R. Furman181 St. James’s University Hospital, Leeds2 Royal Bournemouth Hospital, Bournemouth3 Plymouth University Medical School, Plymouth, United Kingdom5 University College London Hospitals NHS Trust, London, United Kingdom6 MD Anderson Cancer Center, Houston, TX, United States of America7 University of Southampton Hospital Trust, Southampton, United Kingdom7 University of Southampton Hospital Trust, Southampton, United Kingdom8 Amsterdam University Medical Centers, University of Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands9 Institute of Hematology University of Bologna, Bologna, Italy10 Royal Marsden Hospital, London11 Churchill Hospital, Oxford, United Kingdom12 University Medical Center Utrecht, University Utrecht, Utrecht, The Netherlands; on behalf of the Lunenburg Lymphoma Phase I/II Consortium – HOVON/LLPC, Utrecht, Netherlands13 National and Kapodistrian University of Athens, Athens, Greece14 Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, United States of America15 Ernest and Helen Scott Haematological Research Institute and Leicester Cancer Research Centre, University of Leicester, Leicester, United Kingdom16 Cancer Center of Santa Barbara, Santa Barbara17 AstraZeneca, Gaithersburg, MD18 AstraZeneca, South San Francisco19 Weill Cornell Medical College, New York Presbyterian Hospital, New York, NY, United States of Americahttp://journals.lww.com/10.1097/01.HS9.0000847388.33116.c7 |
| spellingShingle | R. Owen H. McCarthy S. Rule S. D’Sa S. Thomas O. Tournilhac F. Forconi M. José Kersten P. Luigi Zinzani S. Iyengar J. Kothari M. Minnema E. Kastritis B. Cheson H. Walter D. Greewald R. Calvo C.-C. Wun R. Furman P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY HemaSphere |
| title | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_full | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_fullStr | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_full_unstemmed | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_short | P1130: ACALABRUTINIB IN TREATMENT-NAIVE OR RELAPSED/REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA: 5-YEAR FOLLOW-UP OF A PHASE 2, SINGLE-ARM STUDY |
| title_sort | p1130 acalabrutinib in treatment naive or relapsed refractory waldenstrom macroglobulinemia 5 year follow up of a phase 2 single arm study |
| url | http://journals.lww.com/10.1097/01.HS9.0000847388.33116.c7 |
| work_keys_str_mv | AT rowen p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT hmccarthy p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT srule p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT sdsa p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT sthomas p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT otournilhac p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT fforconi p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT mjosekersten p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT pluigizinzani p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT siyengar p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT jkothari p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT mminnema p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT ekastritis p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT bcheson p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT hwalter p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT dgreewald p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT rcalvo p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT ccwun p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy AT rfurman p1130acalabrutinibintreatmentnaiveorrelapsedrefractorywaldenstrommacroglobulinemia5yearfollowupofaphase2singlearmstudy |